Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
NARI
|
Thomas Tu
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 15.11% |
$498,400
$99.68 p/Share
|
Jan 27
2021 |
|
JAMF
|
John Strosahl
CEO |
SELL
Open market or private sale
|
Direct | 6,400 Reduced 8.98% |
$236,928
$37.02 p/Share
|
Jan 27
2021 |
|
JAMF
|
Jill Putman
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,715 Reduced 3.48% |
$100,536
$37.03 p/Share
|
Jan 27
2021 |
|
PGNY
|
Norman Payson
Director |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 0.26% |
$222,300
$44.46 p/Share
|
Jan 27
2021 |
|
KBH
|
William R Hollinger
SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 82,651 Reduced 33.51% |
$3,510,188
$42.47 p/Share
|
Jan 27
2021 |
|
PSMT
|
William J Naylon
EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 4.45% |
$139,230
$92.82 p/Share
|
Jan 27
2021 |
|
AAWW
|
Michael Steen
EVP & CMO |
SELL
Open market or private sale
|
Direct | 39,108 Reduced 30.14% |
$2,248,710
$57.5 p/Share
|
Jan 27
2021 |
|
IBRX
|
Barry J. Simon
Director |
SELL
Open market or private sale
|
Direct | 36,626 Reduced 1.14% |
$754,862
$20.61 p/Share
|
Jan 27
2021 |
|
SILK
|
Lucas W. Buchanan
COO & CFO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 6.08% |
$548,600
$54.86 p/Share
|
Jan 27
2021 |
|
ADPT
|
Julie Rubinstein
President and COO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$887,700
$59.18 p/Share
|
Jan 27
2021 |
|
ADPT
|
Lance Baldo
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 100.0% |
$2,366,400
$59.16 p/Share
|
Jan 27
2021 |
|
LPSN
|
Daryl Carlough
SVP, Global & Corp Controller |
SELL
Open market or private sale
|
Direct | 95 Reduced 0.23% |
$6,121
$64.43 p/Share
|
Jan 27
2021 |
|
SLP
|
John Kenneth Paglia
Director |
SELL
Open market or private sale
|
Direct | 3,808 Reduced 100.0% |
$312,637
$82.1 p/Share
|
Jan 27
2021 |
|
SLP
|
John Anthony Di Bella Ii
Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 2,360 Reduced 5.0% |
$188,800
$80.0 p/Share
|
Jan 27
2021 |
|
QURE
|
Matthew C Kapusta
CEO, Managing Director |
SELL
Open market or private sale
|
Direct | 15,749 Reduced 5.94% |
$589,800
$37.45 p/Share
|
Jan 27
2021 |
|
QURE
|
Matthew C Kapusta
CEO, Managing Director |
SELL
Open market or private sale
|
Direct | 15,749 Reduced 5.94% |
$589,800
$37.45 p/Share
|
Jan 27
2021 |
|
GNK
|
Ccp Ii Cayman Gp Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 14,148 Reduced 0.66% |
$108,374
$7.66 p/Share
|
Jan 27
2021 |
|
GNK
|
Ccp Ii Cayman Gp Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 15,852 Reduced 0.72% |
$121,426
$7.66 p/Share
|
Jan 27
2021 |
|
GNK
|
Centerbridge Credit Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 14,148 Reduced 0.66% |
$108,374
$7.66 p/Share
|
Jan 27
2021 |
|
GNK
|
Centerbridge Credit Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 15,852 Reduced 0.72% |
$121,426
$7.66 p/Share
|
Jan 27
2021 |
|
AMRN
|
Steven B Ketchum
EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 421,629 Reduced 52.07% |
$3,377,248
$8.01 p/Share
|
Jan 27
2021 |
|
CSTL
|
Derek J Maetzold
Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct | 14,377 Reduced 1.66% |
$954,920
$66.42 p/Share
|
Jan 27
2021 |
|
RLMD
|
Maged Shenouda
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 57.38% |
$96,030
$32.01 p/Share
|
Jan 27
2021 |
|
RLMD
|
Sergio Traversa
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 11.7% |
$326,900
$32.69 p/Share
|
Jan 27
2021 |
|
RLMD
|
Paul Edward Kelly
COO |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 3.28% |
$163,300
$32.66 p/Share
|
Jan 27
2021 |
|
UPLD
|
John T Mcdonald
CEO |
SELL
Open market or private sale
|
Direct | 1,700 Reduced 0.11% |
$85,017
$50.01 p/Share
|
Jan 27
2021 |
|
UPLD
|
Michael Douglass Hill
CFO, Treasurer & Secretary |
SELL
Open market or private sale
|
Direct | 2,226 Reduced 0.92% |
$111,300
$50.0 p/Share
|
Jan 27
2021 |
|
SDC
|
Steven B. Katzman
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 400,000 Reduced 43.27% |
$6,256,000
$15.64 p/Share
|
Jan 27
2021 |
|
SDC
|
Susan Greenspon Rammelt
EVP, CLO, Secretary |
SELL
Open market or private sale
|
Direct | 75,000 Reduced 21.22% |
$1,125,000
$15.0 p/Share
|
Jan 27
2021 |
|
PETS
|
Gian Fulgoni
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 15.06% |
$460,300
$46.03 p/Share
|
Jan 27
2021 |
|
INO
|
Jacqueline Elizabeth Shea
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 28,336 Reduced 82.62% |
$340,882
$12.03 p/Share
|
Jan 27
2021 |
|
VITL
|
Russell Diez Canseco
PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct | 14,641 Reduced 100.0% |
$388,865
$26.56 p/Share
|
Jan 27
2021 |
|
VRA
|
Patricia R. Miller |
SELL
Open market or private sale
|
Indirect | 3,183 Reduced 0.16% |
$27,056
$8.5 p/Share
|
Jan 27
2021 |
|
VRA
|
P. Michael Miller |
SELL
Open market or private sale
|
Indirect | 3,183 Reduced 0.16% |
$27,056
$8.5 p/Share
|
Jan 27
2021 |
|
DTIL
|
Derek Jantz
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 7,048 Reduced 0.18% |
$82,321
$11.68 p/Share
|
Jan 27
2021 |
|
TRHC
|
Michael Greenhalgh
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 16,000 Reduced 10.21% |
$960,000
$60.0 p/Share
|
Jan 27
2021 |
|
TRHC
|
Brian W Adams
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 5.38% |
$720,000
$60.0 p/Share
|
Jan 27
2021 |
|
IVC
|
Anthony La Placa
Sr. VP, GC, CAO & Secretary |
SELL
Open market or private sale
|
Direct | 100 Reduced 0.13% |
$1,095
$10.95 p/Share
|
Jan 27
2021 |
|
AAOI
|
Stefan J. Murry
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 3.5% |
$36,000
$12.0 p/Share
|
Jan 27
2021 |
|
AAOI
|
Chih Hsiang (Thompson) Lin
President and CEO |
SELL
Open market or private sale
|
Direct | 23,364 Reduced 3.04% |
$264,247
$11.31 p/Share
|
Jan 27
2021 |
|
AAOI
|
Hung Lun (Fred) Chang
Officer |
SELL
Open market or private sale
|
Direct | 5,400 Reduced 5.77% |
$64,800
$12.0 p/Share
|
Jan 27
2021 |
|
GNLN
|
Aaron Lo Cascio
Director |
SELL
Open market or private sale
|
Direct | 44,400 Reduced 28.61% |
$193,140
$4.35 p/Share
|
Jan 27
2021 |
|
EMED
|
Donald J Steinberg
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 13,000 Reduced 0.33% |
$8,190
$0.63 p/Share
|
Jan 27
2021 |
|
EGIO
|
Scott Genereux
Director |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 11.21% |
$75,000
$5.0 p/Share
|
Jan 27
2021 |
|
EGIO
|
Walter Amaral
Director |
SELL
Open market or private sale
|
Direct | 26,271 Reduced 8.75% |
$131,355
$5.0 p/Share
|
Jan 27
2021 |
|
AAM-PA
|
Joshua Harris
Director |
SELL
Open market or private sale
|
Indirect | 10,972 Reduced 100.0% |
$548,600
$50.0 p/Share
|
Jan 27
2021 |
|
AAM-PA
|
Scott Kleinman
Co-President |
SELL
Open market or private sale
|
Direct | 2,700 Reduced 0.16% |
$135,000
$50.0 p/Share
|
Jan 27
2021 |
|
AAM-PA
|
Martin Kelly
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,800 Reduced 0.97% |
$140,028
$50.01 p/Share
|
Jan 27
2021 |
|
CLDR
|
Jim Frankola
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,200 Reduced 0.09% |
$18,540
$15.45 p/Share
|
Jan 27
2021 |
|
MORF
|
Omega Fund V, L.P.
Director |
SELL
Open market or private sale
|
Direct | 9,475 Reduced 0.34% |
$303,958
$32.08 p/Share
|
Jan 27
2021 |